ENOV (Enovis) Tariff Resilience Score: 7/10 (As of Jul. 02, 2026)


ENOV Enovis Corp ENOV
60 GF Score
Price $20.40
GF Value $49.62
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis Tariff Resilience Score?

Enovis ENOV +1.80% 60 Tariff Resilience Score is 7 as of Jul. 02, 2026. GuruFocus rates ENOV with a GF Score™ of 60/100 and a GF Value™ of $49.62 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Enovis ranks better than 98.09% on this metric.

Enovis has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Enovis has Fairly resilient due to diversified manufacturing and sales markets. The company has effectively managed past tariff impacts through alternative sourcing and leveraging its strong market position to adjust pricing strategies.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Enovis might have Highly Resilient.

Enovis  (NYSE:ENOV) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Enovis Tariff Resilience Score Related Terms

ENOV vs INSP, PRCT, AHCO: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Enovis's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enovis Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Enovis's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Enovis's Tariff Resilience Score falls into.


ENOV
60GF Score
Enovis Corp ENOV
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Enovis (ENOV) has a Tariff Resilience Score of 7 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Enovis ranks #16 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Enovis' Tariff Resilience Score too high?
Enovis' current Tariff Resilience Score is 7. Based on the distribution chart, Enovis ranks #16 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Enovis has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enovis' Tariff Resilience Score compare to INSP and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Enovis ranks #16 out of 838 companies for Tariff Resilience Score. This places Enovis in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Enovis's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Based on GuruFocus' analysis, Enovis (ENOV) is currently considered Possible Value Trap. The stock's GF Value™ is $49.62, compared to a current price of $20.40 — trading 58.9% below its estimated fair value. The current Tariff Resilience Score is 7. Enovis' overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Enovis (ENOV), the current Tariff Resilience Score is 7 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $20.40 is trading 58.9% below its estimated GF Value™ of $49.62. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Tariff Resilience Score: 7
  • GF Value™: $49.62 vs. price of $20.40 (58.9% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
60GF Score

Get the complete analysis for ENOV

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.40
Price
$49.62
GF Value